Published on
November 15, 2024
- 18:15 GMT
Hope on the Horizon: Nephrologists Emphasize Need for Innovative C3G Treatments as Novartis and Apellis Prepare Therapies for FDA ...
EXTON, PA, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Complement 3 glomerulopathy (C3G) is a rare, progressive kidney disease characterized by inflammation and kidney damage. Patients with C3G often experience high blood pressure, protein or blood in the urine, …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Media, Advertising & PR
...
